NCT02626533

Brief Summary

Persistent pain and joint stiffness after surgery may interfere with recovery and adversely affect quality of life in up to 40% of patients who have undergone total knee arthroplasty. There is growing evidence that inflammation as well as other medical and psychological factors may be associated with osteoarthritis severity, progression, and associated pain severity. This study aims to identify clinical, biological, and psychological factors that contribute to and predict the development of these complications. Identification of such factors may allow us to target preventative measures to the patients at highest risk of persistent postoperative pain and joint stiffness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
179

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2015

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

December 8, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 10, 2015

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2018

Completed
6.4 years until next milestone

Results Posted

Study results publicly available

July 19, 2024

Completed
Last Updated

December 27, 2024

Status Verified

February 1, 2024

Enrollment Period

1.7 years

First QC Date

December 8, 2015

Results QC Date

May 10, 2022

Last Update Submit

December 23, 2024

Conditions

Keywords

Cytokines

Outcome Measures

Primary Outcomes (1)

  • Presence of Persistent Postoperative Pain Using the Numeric Rating Scale (NRS)

    Defined as numeric rating scale (NRS) pain score ≥4 with activity in the operated joint. A lower score is a better outcome. 0 is no pain, and 10 is worst pain imaginable.

    6 months after date of surgery

Secondary Outcomes (24)

  • Patients Who Experienced Postoperative Joint Stiffness

    6 weeks after date of surgery

  • Postoperative Knee Range of Motion

    6 weeks after date of surgery

  • NRS Pain at Rest on POD1

    1 day after surgery

  • NRS Pain With Movement on POD1

    1 day after surgery

  • Worst NRS Pain on POD1

    1 day after surgery

  • +19 more secondary outcomes

Study Arms (1)

Total knee arthroplasty patients

Patients undergoing total knee arthroplasty for osteoarthritis are enrolled in the study. Blood and joint fluid samples will be obtained from patients. Pain type and severity will be assessed at baseline (enrollment), 4 weeks, 3 months, and 6 months postoperatively.

Procedure: Total Knee Arthroplasty

Interventions

Patients will undergo total unilateral knee arthroplasty for osteoarthritis.

Total knee arthroplasty patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hospital for Special Surgery patients scheduled to undergo unilateral total knee arthroplasty under regional anesthesia.

You may qualify if:

  • Elective primary unilateral total knee arthroplasty
  • Osteoarthritis with radiologic evidence of "severe narrowing" and/or "bone on bone" in the affected joint
  • Patients of surgeons who have agreed to participate in the study
  • Age \> 18 years
  • American Society of Anesthesiologists (ASA) Physical Status 1-3
  • Regional anesthesia
  • Epidural patient-controlled analgesia (PCA) for postoperative pain
  • Adductor canal block for postoperative pain

You may not qualify if:

  • Contraindication to regional anesthesia, NSAIDs, dexamethasone or acetaminophen
  • Use of general anesthesia
  • History of \>6 weeks of daily opioid use and/or any use of non-prescribed opioids
  • Preoperative oral steroid use in the past 6 months
  • Intra-articular steroid injection within one month of scheduled surgery in affected joint
  • Non-English speakers
  • Pre-existing diagnosis of rheumatic disease or autoimmune disease (e.g. rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, multiple sclerosis, Type I diabetes)
  • Peri-articular injections or infusions for postoperative pain
  • Diagnosis of crystalline arthropathy
  • Diagnosis of osteonecrosis
  • Active infection or use of antibiotics
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital for Special Surgery

New York, New York, 10021, United States

Location

Related Publications (1)

  • Sideris A, Malahias MA, Birch G, Zhong H, Rotundo V, Like BJ, Otero M, Sculco PK, Kirksey M. Identification of biological risk factors for persistent postoperative pain after total knee arthroplasty. Reg Anesth Pain Med. 2022 Mar;47(3):161-166. doi: 10.1136/rapm-2021-102953. Epub 2021 Dec 17.

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood, serum, and joint fluid aspirate samples will be collected and stored for analysis.

MeSH Terms

Conditions

Pain

Interventions

Arthroplasty, Replacement, Knee

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Results Point of Contact

Title
Dr. Meghan Kirksey
Organization
Hospital for Special Surgery, Anesthesiology

Study Officials

  • Meghan Kirksey, MD, PhD

    Hospital for Special Surgery, New York

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2015

First Posted

December 10, 2015

Study Start

December 1, 2015

Primary Completion

August 28, 2017

Study Completion

February 28, 2018

Last Updated

December 27, 2024

Results First Posted

July 19, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations